Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ah, right, thanks.. sorry
I'm honored to fix that for ya
Wow, I was right for once ;)
How many to .01?
Aethlon Medical Releases Shareholder Letter
SAN DIEGO, Nov 18, 2008 (BUSINESS WIRE) -- Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that its Chairman and CEO, James A. Joyce has issued the following letter to shareholders.
To our Shareholders,
In my September shareholder letter, I referenced that our organization was heading into a pivotal month as we anticipated initial Hepatitis-C (HCV) treatment results from a safety study being conducted at the Fortis Hospital. The Fortis study allowed us the opportunity to enroll and test four HCV patients who each received a series of three, 4-hour Hemopurifier(R) treatments every other day during the course of five days. When considering the rapid replication of HCV combined with the disease being well established in each patient, we did not have tremendous clinical benefit expectations based on a short-term treatment schedule not optimized to reduce viral load. Much to our surprise, significant viral load reductions were observed in the first three patients. Patient #1 had a 95% reduction in viral load when tested three days post treatment and 89% reduction seven days post treatment. Patient #2 had an 85% reduction of viral load three days post treatment and 50% reduction seven days post treatment. Patient #3 had a 60% reduction of viral load three days post treatment and 83% reduction seven days post treatment. Initial data for the fourth patient has now been received for analysis and will be published in a formal clinical study report.
Since disclosing these outcomes, we have been overwhelmed, yet impassioned by heart wrenching stories of the many HCV-infected individuals who have contacted us seeking treatment. Continued demonstrations of safety and clinical efficacy should drive substantial demand for our Hemopurifier(R) in HCV care. Of the 180 million individuals infected with HCV worldwide, less than half will respond to the established pegylated interferon-ribavirin treatment standard. Our potential opportunities in HCV care include; treating individuals not responsive or unable to endure interferon-ribavirin treatment; serving as an adjunct therapy to improve the benefit of interferon-ribavirin treatment; and, controlling disease progression in the approximate 20% of kidney dialysis patients who are co-infected with HCV. As demonstrated in our clinical studies, this application would provide for our Hemopurifier(R) to be included in series with a dialysis cartridge during normally scheduled treatments. With initial HCV treatment outcomes under our belt, I want to provide guidance on disclosure expectations in the coming months.
HIV Treatment Data -- Initial data resulting from our first-in-man HIV treatment study. Individuals enrolled in the study will receive daily Hemopurifier(R) treatments for a period up to nine consecutive days.
Bioterror and Pandemic Threat Report -- We will publish a report that reviews our Hemopurifier(R) as an advanced broad-spectrum treatment countermeasure against drug and vaccine resistant bioterror and pandemic threats.
30-Day HCV Treatment Data -- We have extended the HCV treatment protocol conducted at the Fortis Hospital to allow for a one month-treatment case study. Completion of this study is expected towards year-end.
Cancer Treatment Report -- A report will be released that reviews the application of the Hemopurifier(R) as an immunotherapeutic strategy to control the spread of tumor secreted exosomes that suppress the immune response in cancer patients.
Government Biodefense Contract -- An update related to our response to a government biodefense contract opportunity submitted on June 4th of this year.
Manufacturing -- Details related to contract manufacturing discussions, including potential large scale manufacturing partnerships. Through these relationships, are working to establish Good Manufacturing Practice (GMP) related to the control and management of manufacturing and quality control testing of our device. Once established, GMP allows the potential to initiate product sales in practitioner driven markets and other markets upon receipt of regulatory clearance to market our technology.
New Product Development -- We will report on a strategy to modify the principles of our Hemopurifier(R) as a means to expand our product pipeline and provide a commercialization pathway that previously did not exist for candidate drug agents.
In closing, I want to thank those shareholders who made certain we were aware of the recent Grand Challenges in Global Health grant opportunity offered by the Bill & Melinda Gates Foundation. Interestingly, as we investigated the details of this grant opportunity, we learned that a highlighted area of interest was approaches for an artificial adjunct to the immune system. That said, I am not aware of any other therapeutic approach beyond our Hemopurifier(R) that could truly be considered an artificial adjunct to the immune system. As such, we did respond to the grant opportunity with a proposal to demonstrate that our device, acting as an artificial adjunct to the immune system can reduce viral load and improve immune function in HIV infected patients, including those fully resistant to drug therapy. Grant recipients will be announced within the next 90 days.
On behalf of our team at Aethlon Medical, I thank you for your continued support.
Very truly yours,
James A. Joyce Chairman, CEO
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
SOURCE: Aethlon Medical, Inc.
Aethlon Medical, Inc.
Jeff Richardson
Senior Director, Communications
858.459.7800 x302
jrichardson@aethlonmedical.com
or
Jim Frakes
Senior VP Finance
858.459.7800 x300
jfrakes@aethlonmedical.com
or
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
New Shareholder letter
http://phx.corporate-ir.net/phoenix.zhtml?c=95588&p=irol-news
Someone needs to knock the rest of those twos out
I hope it wasn't just excitement spilling over from the SPNG board...
Is there news? Did I miss something? ;)
what's the b/a? 2x4?
ask ut to 3?
From the boiler room:
"Posted by: Soapy Bubbles Date: Wednesday, November 12, 2008 11:05:51 PM
In reply to: None Post # of 2300
Pump mailer: VSYM. It's getting a lot of coverage and I am expecting a dump since they have CDs in their 10. So... play smart. "
Is it just me, or are those bottles different than the real ones?
Gotta love the giant "WNBD" on the side when advertising on Ihub...
I see three now... above the most active list, the very top banner, and on the right.
They have all three now.
The anticipation grows...
I bet we'll get a shareholder letter soon.
I haven't given it time, either, obviously. As long as you all keep it boardmarked I'll start it back up again, I promise!
It doesn't mean we have to stop giving our fellow disc golfers picks, though.
Like everyone else, i'm watching PURO and WNBD, and I'm always watching AEMD.
Hope you're right...
Good choice for an advertising venue, I'd say:
"Overview
Investors Hub websites offer the best way for advertisers to reach hundreds of thousands of wealthy, techno-savvy, active investors each month! Our top-ranked financial communities, Investors Hub and Silicon Investor, offer innovative advertising placements and sponsorship opportunities.
We provide various ad types and placements to make sure you communicate your message to our audience effectively. We are always open to new types of ad offerings or ideas that would help promote your products.
Because of the large amount of traffic our sites have, we offer what are probably the lowest prices of all Finance-related websites.
Contact Dunstan Rickard at dunstanr@advfn.com to discuss advertising on Investors Hub or Silicon Investor.
Traffic Stats
600k registered members
~100 million page views per month
~100 million ad inventory per month
400k+ unique users each month
40 million messages posted
Membership Base:
90% of visitors are male
82% are between 30 and 60 years of age
58% have a graduate or post-graduate degree
$125,000 per year average household income
$235,000 average portfolio value (not including real estate or collectibles)
$460,000 average net worth
70% are at management occupational levels or self-employed
88% own one or more homes
Put simply, we attract the most desirable demographic on the Internet. "
Almost time...
yeah, mid April
Lots of messages but no PR..... hmmmmmmmmm
Do you not clean?
YOu better start answering some of that mail! ;)
"GreenPeople averages over 11,000 visitors per day
alexa.com shows Traffic Rank for greenpeople.org: 93,743 (1/06)
Google page ranks is a 6-7 out of 10 (and 1,110 sites link to us)
linkpopularity.com shows
- AltaVista says 1018 sites link to GreenPeople.
- HotBot says 1189 sites link to GreenPeople.
Please let others know about us with a link on your website."
GO ahead crash, tell us that the money would be better spent other ways than to advertise on an investment community website to entice potential shareholders. Thanks in advance.
My Spring Disc Golf Trip:
Day 1) Fly into Denver, spend the night in the city
Day 2) Rent car, drive up to Red Feather Lakes (the Leister, MA of the west) and play its two 5-star courses all day. Spend the night there.
Day 3) Play more of Red Feather Lakes. Visit Rocky Mountain National Park, one of the great US national parks. Play 'Adventure Ridge' course in Vail if we have the time. Stay along Rt. 70.
Day 4) Play any combo of 3 18-hole courses in Vail, Glenwood and Leadville, all conveniently located along the interstate leading to Utah, as we make our way west. Drive to Grand Junction, CO at night.
Day 5) Drive through red rock country. Visit Moab and hike Arches National Park. Play the Base Camp Adventure Lodge disc golf course if we feel up to it. Drive South and motel it somewhere.
Day 6) Drive through the mountains and canyonlands of the Escalante. Visit Bryce Canyon National Park.
Day 7) Visit and hike Zion National Park. Make the 2 hour drive to Las Vegas.
Day 8) Fly out of Las Vegas - McCarron Airport.
http://maps.google.com/maps?f=d&saddr=Denver,+co&daddr=Red+Feather+Lakes,+co+to:Estes+Park,+CO+80517+(United+States+Government+Rocky+Mountain+National+Park:+(Business+Calls))+to:Vail,+Co+to:Grand+Junction,+Co+to:UT-128+to:Moab,+UT+to:Escalante,+UT+to:Bryce+Canyon+to:1+Zion+Lodge+Blvd,+Springdale,+UT+84767+(Zion+National+Park+Lodge:+Front+Desk)+to:Las+Vegas,+NV&hl=en&geocode=%3B%3BFQCgaAId3Aq0-SFx4NgIo19H1w%3B%3B%3BFbJ-TwIdFuh7-Q%3B%3B%3B%3BFWWlNwIdFe5D-SGB4NOSjqvdZA%3B&mra=ls&via=5&sll=38.993572,-108.98437
No kidding. If and when it does though, watch out above.
Give me a break - you know Eric is aware of Ihub and every other popular forum.
Double bottom here... it's a steal
Whoa.. it's been so quiet I lost my mod job! Not cool...
Good call.
Easily. Look at the weekly.
Not yet - everything's green so far ;)
Anyone want asst. mod?
I know this is obvious, but especially with this stock you'll want to take your profits! :) That's the only time I'll say it...
Now, breakout time
I agree...
This part is especially interesting to me..
"Says Jeff Wiebell, CEO and Managing Director of iN Control Security, "Scott and I have years of experience working together in the weapons detection market. His outstanding ability lies in getting decision makers to the table with his solutions-based selling approach. And I mean getting them directly to the table, with Scott delivering the true VIPs -- not their assistants or subordinates -- to high-level conferences in the security industry who represented the upper echelon of D.C. and New York government and enterprise industries.""
Not gonna lie, I feel a little violated having everyone arrive at once... no complaints, though. Welcome, everyone... time to see blue skies all the way to .80
Speak for yourself ;)